J. Goldman & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-31,701
| Closed | -$2.61M | – | 343 |
|
|
2024
Q2 | $2.61M | Sell |
31,701
-101,682
| -76% | -$8.37M | 0.07% | 156 |
|
|
2024
Q1 | $11.6M | Buy |
133,383
+128,549
| +2,659% | +$11.2M | 0.38% | 66 |
|
|
2023
Q4 | $466K | Buy |
+4,834
| New | +$466K | 0.02% | 172 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 248 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 258 |
|
|
2021
Q1 | – | Sell |
-5,811
| Closed | -$510K | – | 329 |
|
|
2020
Q4 | $510K | Buy |
+5,811
| New | +$510K | 0.03% | 221 |
|
|
2020
Q3 | – | Sell |
-2,183
| Closed | -$269K | – | 224 |
|
|
2020
Q2 | $269K | Buy |
+2,183
| New | +$269K | 0.02% | 179 |
|
|
2016
Q4 | – | Sell |
-41,500
| Closed | -$3.84M | – | 205 |
|
|
2016
Q3 | $3.84M | Buy |
+41,500
| New | +$3.84M | 0.22% | 73 |
|
|
2016
Q2 | – | Sell |
-11,900
| Closed | -$982K | – | 204 |
|
|
2016
Q1 | $982K | Buy |
+11,900
| New | +$982K | 0.06% | 139 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 186 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 153 |
|